Life Sciences
Lithuania's life sciences
sector at a glance
Lithuania’s Life Sciences sector is gaining prominence. Boosted by an integrated network of science valleys and educational institutions that supply businesses with a pool of top-notch talent that is eager to learn, the sector is accelerating faster than almost anywhere else in Europe.
Life Sciences companies in Lithuania are among the most profitable in the country, with 90% of their output exported worldwide, yet the market remains unsaturated.
-
85number of Life Science companies having manufacturing or R&D operations presentSource: Moody's Analytics, 2021 -
~2.5%percentage of Lithuania‘s GDP generated by the sectorSource: Lithuanian Biotechnology Association, 2020 -
32ndin the Global Biotechnology Innovation rankingSource: Scientific American Worldview, 2020 -
90%percentage of all pharmaceutical and healthcare production exported, with produce going to over 100 countriesSource: Statistics Lithuania, 2020 -
Main export markets:USA (29%), Germany (14%), China (6.3%), UK (4.7%) and others (46%)Source: Statistics Lithuania, 2020
-
Priority sector
Life Sciences is high on the political agenda, which means we offer exceptional support for soft-landing and are dedicated to deliver.
Source: Lithuania’s Life Sciences Strategy approved by the Parliament, 2018 September
-
FDA-approved regulatory authorities
In 2018 Lithuania entered into a Mutual Recognition Agreement with the FDA, under which the FDA recognized the Lithuanian State Medicine Control Agency as capable of conducting inspections that meet US requirements.
Source: US Food & Drug Administration, 2018
A range of benefits for Life Sciences companies
-
Attractive financial incentives for both R&D and manufacturing activities -
Exceptional government support to ensure smooth business operations in the country
-
A pool of highly skilled and motivated talent ready to create added value for your business
-
A welcoming and value-driven ecosystem, with support available to ensure a fast and efficient soft-landing
Main competencies in Lithuania’s ecosystem
-
Cell & gene therapy -
Biologics Others -
Pharma / drug delivery
-
Medical & Diagnostics -
MedTech & Engineering -
Digital Health & Laser technologies
Emerging Life Sciences competencies
-
Immunotherapy products -
Generics -
Antibodies -
Nucleid acid drugs
Already here
Financial incentives and government support
-
Financial Incentive for Large Scale Projects -
3 Times Deductable Expenses -
Patent Box -
Free Economic Zones -
EU support
Related materials
to download
What’s happening
in the sector
-
Investment climateLithuania will host EFIB’22, European flagship event in biotechnologyOct 05, 2022 -
Life SciencesMeda Surdokaitė among the best young scientists in the European UnionSep 19, 2022 -
Life SciencesThe North American Lithuanian Business Forum 2023
Jun 07, 2023 - Jun 08, 2023
Chicago, USA
